Fortress Biotech, Inc. (FBIO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$88.63M
Year ended 2017-12-31
2013-12-31: -$35.76M2014-12-31: -$20.63M2015-12-31: -$50.51M2016-12-31: -$64.77M2017-12-31: -$88.63M-$88.63M
2013-12-31 EBITDA (USD) 2017-12-31
Period endedEBITDAChange YoYSource filing
2017-12-31-$88.63Mn/c2019-03-18, From 2017-01-01
2016-12-31-$64.77Mn/m2018-03-16, From 2016-01-01
2015-12-31-$50.51Mn/m2018-03-16, From 2015-01-01
2014-12-31-$20.63Mn/m2017-03-16, From 2014-01-01
2013-12-31-$35.76Mn/a2016-03-15, From 2013-01-01